Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with unparalleled accuracy.
Behind declines for shares of Salesforce and Chevron, the Dow Jones Industrial Average is falling Monday morning. The Dow DJIA, -0.53% was most recently trading 211 points lower , as shares of Salesforce CRM, -2.54% and Chevron CVX, -2.77% have contributed to the blue-chip gauge's intraday decline. Salesforce's shares have dropped $5.83, or 2.9%, while those of Chevron have dropped $4.63, or 2.8%, combining for an approximately 69-point drag on the Dow.
Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Chevron to acquire Hess Corp. in $53 billion all-share dealBarbara Kollmeyer is based in Madrid, where she leads MarketWatch's pre-markets coverage of financial markets and writes the Need to Know column. She has worked in London and Los Angeles for MarketWatch previously. Follow her on Twitter bkollmeyer.
Baca lebih lajut »
Chevron to buy Hess Corp for $53 billion in stockChevron to buy Hess Corp for $53 billion in stock
Baca lebih lajut »
Chevron to buy Hess Corp for $53 billion in all-stock dealChevron said on Monday it will buy smaller rival Hess in a $53-billion all-stock deal. Chevron is offering $171 for every Hess share, implying a premium of…
Baca lebih lajut »
Chevron to acquire Hess Corp for $53 billion in stock in latest oil megadealChevron to acquire Hess Corp for $53 billion in stock in latest oil megadeal
Baca lebih lajut »
Chevron, Hess, Roivant, Textainer, Microsoft, Alphabet, and More Stock Market MoversChevron will buy Hess in all-stock deal valued at $53 billion, Roche agrees to buy a developer of a drug for people suffering from inflammatory bowel disease...
Baca lebih lajut »